MUMBAI—Saregama’s South TV production arm added another feather to its cap, when their massively popular show, “Chandralekha,” completed 1000 episodes. The actors commemorated the landmark episode with a celebration on set, with the crew and director joining in. After a three-year run, “Chandralekha” has remained one of the most popular shows of the region consistently.
B.R. Vijayalakshmi, who heads the Saregama television production arm in Chennai, said, “It’s a matter of great pride that this is our third show to enter the 1000 episode hall of fame, after ‘Athi Pookal’ and ‘Valli.’ This is testimony to the fact that we are producing content that is not just entertaining but consistently finds relevance with its viewers. I would like to thank my fabulous actors and an equally hardworking crew, who has made this journey so creatively satisfying. And finally, thanks to our very discerning audience whose constant love and support has made us a part of their lives every afternoon.”
Vikram Mehra, managing director, Saregama India, said, “We are glad to be associated with Sun TV, the leading entertainment channel in the region, and also extend our gratitude for their constant support.”
“Chandralekha” revolves around the conflict between two diverse women whose paths converge. They were switched at birth and ended up growing in contrasting backdrops, thereby molding their personalities and their way of dealing with life.
Shweta Bandekar, popular for playing the lead in comedian Vivek’s film “Naan Than Bala,” is playing the role of Chandra and the second lead Lekha is played by actress Nagashree. The serial also features popular actors like Meena Kumari, Niharika, Rishi, Sakshi Siva, Dhanush, and Rajesh. Guru Sampath Kumar has written the screenplay, and K. Shanmugam has penned the dialogues. The camerawork is being handled by K. S. Udhayashankar, and the series is being directed by Sundaresan.
The South television business of Saregama started in June 2001 and has produced over 8000 hours of TV content in all South languages.